Delivery Order SPE2DB20D3505-SPE2DB24FU8V3

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,730.69 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,564,675,611 units of epinephrine 0.15 mg auto-injectors. The contract has a firm fixed price and an ultimate completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,196.24 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,702,417 units of Epinephrine 0.3 mg auto-injectors. This contract has a completion date of May 24, 2024 and is not set aside. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,494.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,189,968 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,128.60 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,339,573 units of epinephrine 0.3 mg auto-injector devices. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,637.05 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,563,113,017 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of December 18, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,603,841 units of epinephrine 0.3 mg auto-injector 2-packs. The $47,777.78 contract has a completion date of May 15, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to provide 4,564,803,699 units of Epinephrine 0.3 mg auto-injectors. The $3,900.60 firm fixed-price contract has a completion date of June 5, 2024 and is not set aside for any small business program. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of an Epinephrine 0.15 mg auto-injector product. The award, valued at $1,794.36, has an ultimate completion date of April 4, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU8V3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $4,339.07 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.15 mg auto-injectors. This contract has an ultimate completion date of August 28, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:02 AM